D. Sprij-Mooij

发表

Cushing's disease and hypertension: in vivo and in vitro study of the role of the renin-angiotensin-aldosterone system and effects of medical therapy.

C. de Bruin, R. Netea-Maier, S. Lamberts, 2014, European journal of endocrinology.

Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells.

D. Hoyer, S. Lamberts, M. Culler, 2005, American journal of physiology. Endocrinology and metabolism.

Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion.

L. Nieman, C. de Bruin, S. Lamberts, 2012, The Journal of clinical endocrinology and metabolism.

Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.

C. de Bruin, S. Lamberts, P. V. van Koetsveld, 2008, Journal of molecular endocrinology.

The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.

S. Lamberts, A. J. van der Lely, P. V. van Koetsveld, 2004, The Journal of clinical endocrinology and metabolism.

Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.

S. Schulz, C. de Bruin, J. Kros, 2013, The Journal of clinical endocrinology and metabolism.

Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly.

J. Kros, F. Minuto, L. Hofland, 2013, The Journal of clinical endocrinology and metabolism.

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

S. Lamberts, P. V. van Koetsveld, L. Hofland, 2005, European journal of endocrinology.

Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas.

J. Romijn, C. de Bruin, S. Lamberts, 2009, The Journal of clinical endocrinology and metabolism.

Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats.

R. Woutersen, J. Jansen, L. Rovati, 1992, British Journal of Cancer.

Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane.

G. Vitale, E. Speel, S. Lamberts, 2013, Endocrine-related cancer.

The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells.

M. D. De Martino, S. Lamberts, P. V. van Koetsveld, 2012, Endocrine-related cancer.

The IGF pathway is activated in insulinomas but downregulated in metastatic disease.

E. Speel, L. Hofland, Y. Versleijen-Jonkers, 2018, Endocrine-related cancer.

Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors

C. V. van Eijck, M. D. De Martino, P. V. van Koetsveld, 2013, Endocrine connections.

Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells

S. Lamberts, P. V. van Koetsveld, L. Hofland, 2016, Neuroendocrinology.

Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.

H. Pijl, R. Roos, J. Romijn, 2009, The Journal of clinical endocrinology and metabolism.

Effects of interferons α/β on the proliferation of human micro- and macrovascular endothelial cells.

G. Vitale, C. V. van Eijck, E. Croze, 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.

C. de Bruin, S. Lamberts, P. V. van Koetsveld, 2008, Journal of molecular endocrinology.

Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.

H. Pijl, R. Roos, J. Romijn, 2009, The Journal of clinical endocrinology and metabolism.

Cushing's disease and hypertension: in vivo and in vitro study of the role of the renin-angiotensin-aldosterone system and effects of medical therapy.

C. de Bruin, R. Netea-Maier, R. Feelders, 2014, European journal of endocrinology.

The IGF pathway is activated in insulinomas but downregulated in 1 metastatic disease 2

A. Perren, M. Henfling, F. Ramaekers, 2022 .